1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with desloratadine in 2 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (desloratadine) | Trials (desloratadine) | Recent Studies (post-2010) (desloratadine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 465 | 146 | 166 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | desloratadine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.03 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 1.116 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.107 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.339 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.292 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.267 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 2.146 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.446 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 1.116 | |
| Histamine H2 receptor | Homo sapiens (human) | 1.099 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.033 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.03 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.23 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0059 | |
| D(3) dopamine receptor | Homo sapiens (human) | 1.906 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.043 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 2.171 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 3.879 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bachert, C | 1 |
| Fan, G; Hong, Z; Wei, H; Wen, J; Wu, Y | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and desloratadine
| Article | Year |
|---|---|
Decongestant efficacy of desloratadine in patients with seasonal allergic rhinitis.
Topics: Chemotaxis, Leukocyte; Cholinergic Antagonists; Eosinophils; Histamine H1 Antagonists; Humans; Loratadine; Platelet Activating Factor; Rhinitis, Allergic, Seasonal; Severity of Illness Index; Time Factors; Treatment Outcome | 2001 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and desloratadine
| Article | Year |
|---|---|
Simultaneous determination of rupatadine and its metabolite desloratadine in human plasma by a sensitive LC-MS/MS method: application to the pharmacokinetic study in healthy Chinese volunteers.
Topics: Adult; Asian People; Calibration; Chromatography, Liquid; Cyproheptadine; Drug Stability; Female; Formates; Freezing; Histamine H1 Antagonists, Non-Sedating; Humans; Loratadine; Male; Methanol; Molecular Structure; Platelet Activating Factor; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Tablets; Tandem Mass Spectrometry; Time Factors; Water; Young Adult | 2009 |